Overview

Methylene Blue in Severe Sepsis and Septic Shock

Status:
Unknown status
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This study is to see whether the intravenous administration of methylene blue improves the outcome in severe sepsis and septic shock.
Phase:
Phase 3
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Methylene Blue